Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3SHIFFMAN, Mitchell L; MIHAS, Anastasios A; MILLWALA, Farida et al.The American journal of gastroenterology. 2007, Vol 102, Num 4, pp 761-766, issn 0002-9270, 6 p.Article

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1 p31 and 7q32 risk variantsJURAN, Brian D; HIRSCHFIELD, Gideon M; SCHLICHT, Erik M et al.Human molecular genetics (Print). 2012, Vol 21, Num 23, pp 5209-5221, issn 0964-6906, 13 p.Article

Comparison of three commercially available assays for HCV RNA using the international unit standard: Implications for management of patients with chronic hepatitis C virus infection in clinical practiceSHIFFMAN, Mitchell L; FERREIRA-GONZALEZ, Andrea; REDDY, K. Rajender et al.The American journal of gastroenterology. 2003, Vol 98, Num 5, pp 1159-1166, issn 0002-9270, 8 p.Article

Hepatitis B virus genotypes in the United States: Results of a nationwide studyCHU, Chi-Jen; KEEFFE, Emmet B; LOK, Anna S. F et al.Gastroenterology (New York, NY. 1943). 2003, Vol 125, Num 2, pp 444-451, issn 0016-5085, 8 p.Article

Variants at IRFS-TNP03, 17q12-21 and MMEL1 are associated with primary biliary cirrhosisHIRSCHFIELD, Gideon M; XIANGDONG LIU; MASON, Andrew L et al.Nature genetics. 2010, Vol 42, Num 8, pp 655-657, issn 1061-4036, 3 p.Article

The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndromeCHEUNG, Onpan; KAPOOR, Ashwani; SANYAL, Arun J et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 4, pp 1091-1100, issn 0270-9139, 10 p.Article

Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis CSTRAVITZ, R. Todd; CHUNG, Harold; STERLING, Richard K et al.The American journal of gastroenterology. 2005, Vol 100, Num 6, pp 1415-1419, issn 0002-9270, 5 p.Article

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT valuesMOFRAD, Pouneh; CONTOS, Melissa J; HAQUE, Mahmadul et al.Hepatology (Baltimore, Md.). 2003, Vol 37, Num 6, pp 1286-1292, issn 0270-9139, 7 p.Article

Mild Alcohol Consumption is Not Associated With Increased Fibrosis in Patients With Chronic Hepatitis CCHEUNG, Onpan; STERLING, Richard K; SHIFFMAN, Mitchell L et al.Journal of clinical gastroenterology. 2011, Vol 45, Num 1, pp 76-82, issn 0192-0790, 7 p.Article

Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alphaSHIFFMAN, Mitchell L; SALVATORE, Jennifer; HUBBARD, Sarah et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 2, pp 371-379, issn 0270-9139, 9 p.Article

The spectrum of chronic hepatitis C virus infection in the Virginia correctional system : Development of a strategy for the evaluation and treatment of inmates with HCVSTERLING, Richard K; BROWN, Robert S; HOFMANN, Charlotte M et al.The American journal of gastroenterology. 2005, Vol 100, Num 2, pp 313-321, issn 0002-9270, 9 p.Article

Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves OutcomeSHERMAN, Morris; STRAVITZ, Richard Todd; CITES, Ho-Chong S et al.The American journal of medicine. 2008, Vol 121, Num 2, issn 0002-9343, 89-90, 119-126 [10 p.]Article

Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA ExpressionCHEUNG, Onpan; PURI, Puneet; EICKEN, Christoph et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 6, pp 1810-1820, issn 0270-9139, 11 p.Article

Differences between caucasian, african american, and hispanic patients with primary biliary cirrhosis in the united statesPETERS, Marion G; DI BISCEGLIE, Adrian M; COMBES, Burton et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 3, pp 769-775, issn 0270-9139, 7 p.Article

Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosisCOMBES, Burton; EMERSON, Scott S; BENNER, Kent G et al.Hepatology (Baltimore, Md.). 2005, Vol 42, Num 5, pp 1184-1193, issn 0270-9139, 10 p.Article

Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosisCOMBES, Burton; LUKETIC, Velimir A; PETERS, Marion G et al.The American journal of gastroenterology. 2004, Vol 99, Num 2, pp 264-268, issn 0002-9270, 5 p.Article

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndromeSANYAL, Arun J; CONTOS, Melissa J; STERLING, Richard K et al.The American journal of gastroenterology. 2003, Vol 98, Num 9, pp 2064-2071, issn 0002-9270, 8 p.Article

Treatment of chronic hepatitis C in patients who failed interferon monotherapy : Effects of higher doses of interferon and ribavirin combination therapySHIFFMAN, Mitchell L; HOFMANN, Charlotte M; GABBAY, Joubin et al.The American journal of gastroenterology. 2000, Vol 95, Num 10, pp 2928-2935, issn 0002-9270Article

Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels : Comparison of hepatic histology and response to interferon therapySHIFFMAN, Mitchell L; STEWART, Charmaine A; HOFMANN, Charlotte M et al.The Journal of infectious diseases. 2000, Vol 182, Num 6, pp 1595-1601, issn 0022-1899Article

The Predictors of the Presence of Varices in Patients with Primary Sclerosing CholangitisTREEPRASERTSUK, Sombat; KOWDLEY, Kris V; SCHMOLL, Jeff et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 4, pp 1302-1310, issn 0270-9139, 9 p.Article

High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing CholangitisEATON, John E; SILVEIRA, Marina G; JORGENSEN, Roberta et al.The American journal of gastroenterology. 2011, Vol 106, Num 9, pp 1638-1645, issn 0002-9270, 8 p.Article

High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing CholangitisLINDOR, Keith D; KOWDLEY, Kris V; MOONEY, Jody et al.Hepatology (Baltimore, Md.). 2009, Vol 50, Num 3, pp 808-814, issn 0270-9139, 7 p.Article